Questions: Lipoproteins: Structure and Lipid Transport

Question 1

A patient's blood panel shows high LDL and low HDL. Why does this combination indicate elevated cardiovascular risk?

• A. High LDL stores excess fat in adipose tissue; low HDL means insufficient energy availability for cellular repair
• B. High LDL means more cholesterol is being delivered to peripheral tissues including artery walls, while low HDL means less cholesterol is being scavenged from those tissues and returned to the liver
• C. LDL particles are toxic because they carry protein that damages endothelial cells; HDL neutralizes this toxicity
• D. High LDL indicates liver dysfunction causing fat accumulation; low HDL indicates kidney dysfunction impairing lipid clearance

Answer: (B)

LDL's function is to deliver cholesterol to peripheral tissues via LDL receptors; when LDL is abundant, more cholesterol reaches and can accumulate in artery walls, driving atherosclerotic plaque formation. HDL's function is reverse cholesterol transport — it scavenges excess cholesterol from peripheral tissues and returns it to the liver for excretion. Low HDL means this clearance pathway is underactive. The 'good/bad' shorthand captures the directional asymmetry: LDL delivers cholesterol outward, HDL removes it back toward the liver.

Question 2

As a VLDL particle circulates and lipoprotein lipase hydrolyzes its triglyceride cargo at capillary walls, what happens to the particle's density?

• A. Density decreases as the particle loses mass and expands, eventually becoming a chylomicron
• B. Density stays the same because the phospholipid shell expands proportionally to replace lost core lipids
• C. Density increases as the triglyceride-rich core shrinks, leaving the particle relatively enriched in protein and cholesterol
• D. Density increases initially but decreases again when the particle reaches the liver and exchanges apolipoproteins

Answer: (C)

Lipoprotein density reflects the ratio of lipid (low density) to protein (high density). VLDL begins very lipid-rich and protein-poor, hence very low density. As lipoprotein lipase removes triglycerides from the core, the lipid-to-protein ratio falls — the remaining core becomes cholesterol ester-rich and the surface apolipoproteins make up a larger fraction of total mass. This progressive densification produces IDL then LDL — the naming convention directly reflects this maturation process. LDL is essentially a cholesterol-delivery remnant of VLDL's triglyceride delivery job.

Question 3

Apolipoproteins on the lipoprotein surface determine which cellular receptors recognize and take up each lipoprotein class, acting as address labels that direct the particle to its metabolic destination.

• T. True
• F. False

Answer: True

Apolipoproteins are not merely structural — they are functional determinants of metabolic fate. ApoB-100 on LDL is recognized by the LDL receptor on hepatocytes and peripheral cells. ApoE on remnant particles is recognized by hepatic receptors for clearance. ApoA-I on HDL activates LCAT (lecithin-cholesterol acyltransferase) and interacts with ABCA1 for cholesterol efflux. Defects in specific apolipoproteins (as in familial hypercholesterolemia where LDL receptor or ApoB-100 is mutated) cause lipoprotein accumulation because the address label system fails.

Question 4

HDL is called 'good cholesterol' because it contains a healthier type of fat than LDL, making it less likely to deposit in artery walls.

• T. True
• F. False

Answer: False

The 'good/bad' distinction is about transport direction, not fat quality. Both LDL and HDL carry the same cholesterol molecule. HDL is cardioprotective because it performs reverse cholesterol transport — it accepts excess cholesterol from peripheral tissues (including artery walls) and carries it back to the liver for excretion in bile. LDL is associated with risk because its function is to deliver cholesterol outward to tissues, and excess LDL means excess delivery to artery walls. The cholesterol is identical; the traffic direction differs.

Question 5

Why are lipoproteins necessary for lipid transport in blood, and how does their structure solve the problem they address?

Model answer: Lipids are hydrophobic and cannot dissolve in aqueous blood plasma. Lipoproteins solve this by packaging hydrophobic cargo (triglycerides, cholesterol esters) in a hydrophobic core, surrounded by a hydrophilic shell of phospholipids and apolipoproteins that interfaces with water. The amphipathic shell makes the particle water-soluble while keeping the hydrophobic cargo interior protected.

This is the fundamental transport problem in lipid biology: moving water-insoluble molecules through a water-based circulatory system. The lipoprotein architecture — essentially a micelle-like particle with a hydrophobic core and hydrophilic surface — is the body's engineering solution. The apolipoproteins on the surface add a second layer of functionality: they determine where the particle goes and which enzymes act on it, turning a simple packaging problem into a sophisticated targeted delivery system.